hg_191164.1

Basic information about the TSS

---

TSS ID: hg_191164.1 Species: human Chr: chr22		Start: 20859486 End: 20859489 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000439214.1 uc062bvo.1 Distance: -4 GeneID: 9342 HGNC/MGI_ID: HGNC:11133 UniProt_ID: C9JAF7

Gene_name: synaptosome associated protein 29kDa Gene_symbol: SNAP29 Gene_synonyms: CEDNIK SNAP-29 Gene_source: HGNC:11133

TATA-Box annotation

---

Distance to TSS:	484
Nearest PromoterID:	NM_004782
Entrez ID:	9342
Nearest Unigene:	Hs.108002
Nearest Refseq:	NM_004782
Nearest Ensembl:	ENSG00000099940
Gene Name:	synaptosome associated protein 29kDa
Gene Alias:	CEDNIK
Gene Description:	synaptosome associated protein 29
Gene Type:	protein-coding
CpG%:	0.02
GC%:	0.40796
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SNAP29 p2@SNAP29 p3@SNAP29 p4@SNAP29
Sample		p1@SNAP29	p2@SNAP29	p3@SNAP29	p4@SNAP29
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	6.62	5.06	9.55	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	7.89	4.86	11.13	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	9.26	4.44	8.68	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	5.82	3.74	6.86	1.25
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	4.95	2.92	6.07	0.67
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	8.14	2.71	7.75	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	10.02	6.54	12.64	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	7.99	4.60	12.60	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	10.04	8.33	15.39	0.85
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	12.75	6.38	19.71	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	9.30	6.47	21.42	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	9.76	8.54	17.89	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	16.60	5.96	2.26	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.04	5.86	4.21	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.29	3.51	2.20	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	14.33	3.77	2.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.85	7.43	1.53	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	21.51	4.22	3.37	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	17.59	1.60	3.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.54	3.91	2.11	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.77	5.08	3.21	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	10.88	5.35	2.59	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	15.25	5.04	2.20	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.35	4.61	2.18	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.67	4.13	3.10	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	14.24	4.43	2.53	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.09	2.20	1.10	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	20.51	6.13	3.30	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.66	5.33	2.58	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	12.67	7.06	4.34	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	11.10	3.77	3.56	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.72	2.93	1.56	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	12.66	4.01	2.74	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	19.63	2.97	2.47	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	13.84	4.86	2.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.37	3.64	1.53	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.40	4.50	2.04	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	16.12	5.04	2.62	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	15.13	5.67	2.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.52	3.12	2.40	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.88	5.18	3.53	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	12.74	3.37	1.90	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.54	3.80	1.69	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	10.49	2.97	2.62	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	9.03	6.02	3.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	11.17	3.49	2.56	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	9.12	3.12	2.64	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	11.92	5.36	1.19	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.38	4.55	3.11	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.72	1.82	2.83	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	7.79	1.43	2.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	11.79	2.89	1.78	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	9.23	3.19	1.42	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.61	1.66	3.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	11.75	3.36	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	12.40	2.30	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	7.45	3.57	2.59	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	4.82	2.57	1.61	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	10.37	3.14	1.57	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	2.12	4.94	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	2.24	1.68	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	4.78	1.59	0.80	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	8.49	2.04	1.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	4.55	3.25	1.95	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.74	3.90	2.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	3.90	3.90	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	3.97	2.98	1.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	4.69	4.22	1.88	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	5.96	2.98	1.99	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	4.02	5.26	4.95	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	4.89	3.97	3.06	0.61
Adipocyte - breast, donor1	11376-118A8	12.51	4.59	3.96	0.48
Adipocyte - breast, donor2	11327-117E4	15.88	6.26	5.29	0.96
Adipocyte - omental, donor1	11473-119C6	12.60	2.67	3.94	2.29
Adipocyte - omental, donor2	11474-119C7	11.21	5.98	8.97	0.00
Adipocyte - omental, donor3	11475-119C8	7.03	7.37	6.03	0.33
Adipocyte - perirenal, donor1	11476-119C9	8.93	6.38	3.19	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	6.60	3.30	2.20	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	14.00	6.77	3.61	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	10.60	3.48	5.39	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	14.86	13.69	5.67	1.17
Adipocyte differentiation, day04, donor2	13022-139D7	12.10	7.21	4.38	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	13.94	7.53	6.13	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	21.75	9.40	7.64	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.10	14.88	9.41	1.61
Adipocyte differentiation, day08, donor2	13023-139D8	10.65	8.39	6.78	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	11.73	6.40	4.80	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	5.01	4.45	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	18.30	9.15	9.57	1.66
Adipocyte differentiation, day12, donor2	13024-139D9	9.54	5.78	5.53	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	13.74	4.25	6.87	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	14.01	7.31	7.92	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	11.93	8.62	8.84	2.87
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	3.23	4.66	1.08
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	5.99	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.31	9.18	6.48	1.44
Amniotic Epithelial Cells, donor2	11613-122A2	8.37	8.37	5.02	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	8.01	8.01	7.40	1.03
Anulus Pulposus Cell, donor1	11248-116E6	21.17	5.26	6.06	0.69
Anulus Pulposus Cell, donor2	11463-119B5	15.18	5.88	5.14	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.58	5.39	5.39	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	15.63	4.78	8.25	1.74
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	17.12	2.14	12.84	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.65	4.18	5.68	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	13.91	5.06	2.53	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	12.54	0.66	3.96	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	5.85	2.60	1.62
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	12.14	2.43	7.28	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	9.50	2.38	4.75	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.04	6.78	5.27	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.24	5.08	6.53	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.33	4.45	4.78	0.66
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	10.92	12.28	5.46	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	10.25	4.67	3.32	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	11.25	4.82	4.29	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	8.88	3.40	5.29	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	15.24	1.60	3.74	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	12.68	0.98	2.93	2.93
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	10.12	4.81	5.14	1.16
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	3.60	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	31.86	0.00	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	12.69	6.52	6.35	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	0.00	4.19	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	8.74	2.91	3.88	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	10.62	4.55	5.69	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	9.69	1.21	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	6.84	3.42	5.13	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	4.28	4.06	1.07
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.81	3.36	6.19	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	10.79	1.88	4.69	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	10.61	6.75	5.14	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	0.71	3.57	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	14.04	3.51	4.68	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.55	3.91	6.62	1.81
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	1.19	2.38	2.38
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	4.07	5.09	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.72	3.82	4.33	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	3.18	5.72	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	13.38	7.77	5.61	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	10.37	3.81	3.39	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	10.15	2.90	2.32	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	4.72	2.83	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	12.04	2.71	4.24	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	6.95	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.43	6.86	5.79	1.93
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	10.23	4.81	3.61	3.01
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	8.02	3.64	3.64	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	9.88	7.82	5.98	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.39	4.83	3.81	1.27
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.94	3.72	4.34	1.45
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.10	5.51	4.90	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	14.82	3.35	3.82	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	11.75	6.21	3.77	1.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	9.15	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.85	8.86	4.98	1.66
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	11.12	3.18	4.50	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	14.54	2.54	4.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	18.67	6.88	7.86	0.98
Astrocyte - cerebellum, donor2	11580-120F5	16.94	9.41	8.22	1.20
Astrocyte - cerebellum, donor3	11661-122F5	10.07	6.50	6.92	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	11.50	5.93	7.32	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	9.06	10.84	7.93	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	11.49	10.14	8.50	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	17.66	9.40	8.83	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	18.67	11.90	7.89	1.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	18.32	11.95	8.76	1.48
Basophils, donor1	12241-129G9	22.75	6.02	5.23	0.00
Basophils, donor2	12242-129H1	35.72	5.77	5.05	0.00
Basophils, donor3	12243-129H2	23.96	11.32	8.23	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	4.10	4.31	6.25	1.94
Bronchial Epithelial Cell, donor2	11591-120G7	2.29	3.66	4.57	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	7.17	14.35	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	4.39	4.39	5.65	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	2.91	4.16	7.90	1.04
Bronchial Epithelial Cell, donor6	11461-119B3	5.30	6.68	5.99	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	5.40	3.96	6.84	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	22.47	5.36	12.16	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	12.11	6.99	10.71	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	28.46	7.04	8.63	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	0.00
CD14+ Monocytes, donor1	11224-116B9	18.03	6.20	7.33	1.13
CD14+ Monocytes, donor2	11305-117B9	28.03	10.21	8.72	0.56
CD14+ Monocytes, donor3	11381-118B4	20.64	9.44	6.59	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	46.14	12.17	10.19	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	47.01	15.16	6.82	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	47.34	20.38	13.81	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	26.74	6.65	10.41	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	18.10	6.94	5.73	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	30.56	10.66	3.32	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	15.74	5.86	8.04	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	15.46	4.97	6.90	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.59	6.45	6.45	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.53	5.29	4.90	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.89	5.70	3.74	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	24.16	6.75	7.40	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	12.41	3.28	4.45	0.94
CD14+ monocytes - treated with Candida, donor2	11878-125C6	30.63	4.22	10.03	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	27.73	6.66	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	23.95	6.40	6.54	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	15.96	4.99	5.59	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	19.36	6.87	7.70	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	15.33	5.03	7.09	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.23	4.52	3.62	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	20.08	3.06	6.55	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.06	5.11	6.99	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	23.90	7.68	5.06	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	31.98	6.73	5.89	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	9.92	2.94	4.59	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	7.40	3.17	8.10	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	12.28	4.83	8.34	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	11.16	3.84	5.06	0.87
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	13.38	6.32	7.06	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	26.30	7.33	4.74	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	11.47	4.09	4.50	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.82	1.85	4.40	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	17.40	4.87	4.41	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	49.48	8.28	6.10	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	54.05	9.70	8.55	1.39
CD14+CD16+ Monocytes, donor3	11912-125G4	32.06	8.66	3.03	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	42.51	8.56	8.88	0.47
CD14+CD16- Monocytes, donor2	11799-124C8	42.44	8.73	10.83	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	35.90	10.26	9.14	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	55.63	8.17	5.36	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	68.07	11.20	8.56	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	44.21	10.11	6.53	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	16.26	16.26	10.16	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	14.24	5.42	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	8.28	11.39	4.14	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	10.66	11.73	8.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	8.58	9.65	4.82	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	9.13	8.42	7.02	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	9.41	5.49	10.20	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	19.77	10.55	5.27	1.32
CD19+ B Cells, donor1	11544-120B5	7.40	6.58	4.11	2.47
CD19+ B Cells, donor2	11624-122B4	8.71	5.08	7.25	0.00
CD19+ B Cells, donor3	11705-123B4	7.57	4.04	7.57	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	28.28	20.20	26.26	4.04
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	24.37	15.98	23.17	5.19
CD34+ Progenitors, donor1	11545-120B6	17.07	4.02	2.01	0.00
CD34+ Progenitors, donor2	11625-122B5	16.29	3.93	6.18	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	22.55	7.89	9.77	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	32.02	6.54	7.67	0.00
CD4+ T Cells, donor1	11225-116C1	20.35	9.64	10.71	1.79
CD4+ T Cells, donor2	11306-117C1	17.15	9.19	9.19	3.06
CD4+ T Cells, donor3	11382-118B5	21.04	6.40	6.40	1.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	42.62	10.98	15.06	2.55
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	48.51	10.33	13.48	1.80
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	35.36	6.04	6.90	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	19.91	7.11	5.22	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.05	8.43	10.53	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	6.59	6.59	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	30.35	7.51	10.41	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	38.81	12.88	11.86	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	22.73	8.22	6.61	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	13.90	7.62	5.83	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	23.76	10.13	12.58	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	23.76	6.60	3.52	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	37.10	6.75	11.38	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	18.49	9.77	11.22	1.25
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	13.37	6.35	5.68	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	16.32	6.53	6.80	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	15.01	7.50	16.61	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	26.90	8.97	5.38	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	31.71	8.53	11.13	1.48
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	24.26	6.28	9.96	2.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.01	10.30	7.15	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	16.18	8.60	3.03	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	21.66	9.96	9.53	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	19.61	8.72	5.67	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	19.30	11.88	12.37	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	22.16	12.92	4.62	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	18.15	5.58	12.56	4.19
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	22.71	10.25	8.31	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	24.05	12.02	8.10	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	23.10	18.48	10.78	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	18.98	13.25	8.59	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	22.16	16.62	9.69	2.77
CD8+ T Cells, donor1	11226-116C2	24.88	7.53	5.89	0.98
CD8+ T Cells, donor2	11307-117C2	24.40	7.51	8.26	1.50
CD8+ T Cells, donor3	11383-118B6	19.19	9.34	6.82	1.51
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	11.24	2.98	5.28	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	12.70	3.12	5.99	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	13.13	3.01	3.28	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	14.41	2.40	4.80	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	11.04	3.60	3.84	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	14.55	2.27	5.46	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	11.73	3.04	5.87	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	11.84	1.58	5.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	12.43	3.52	4.69	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	13.58	5.43	4.53	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	13.94	1.74	6.68	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	10.92	2.40	6.39	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.07	2.19	3.50	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	7.29	0.91	3.19	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	12.68	1.49	3.73	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	10.08	3.24	8.28	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	10.65	4.32	5.18	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	12.02	3.30	3.54	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	15.85	3.49	4.75	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	11.69	2.77	6.77	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	10.58	3.53	5.13	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	9.94	3.82	7.27	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	11.03	2.76	4.34	1.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	10.59	3.78	0.76	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	8.83	4.82	4.01	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	7.69	4.20	6.29	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	12.02	7.01	8.01	1.00
Cardiac Myocyte, donor1	11525-119I4	16.45	1.83	9.14	1.83
Cardiac Myocyte, donor2	11605-120I3	17.29	4.94	5.93	0.00
Cardiac Myocyte, donor3	11686-122I3	14.63	11.15	6.95	1.05
Chondrocyte - de diff, donor1	11261-116G1	11.44	6.24	8.67	0.35
Chondrocyte - de diff, donor2	11338-117F6	7.11	6.04	5.69	1.78
Chondrocyte - de diff, donor3	11410-118E6	17.52	6.71	6.26	0.91
Chondrocyte - re diff, donor2	11339-117F7	24.17	21.49	17.91	1.79
Chondrocyte - re diff, donor3	11411-118E7	8.90	8.09	4.04	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	13.66	5.16	6.77	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	7.91	7.05	5.56	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	10.62	5.84	6.64	1.42
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	16.69	13.76	28.15	1.74
Corneal Epithelial Cells, donor1	11526-119I5	6.15	5.49	5.71	1.32
Corneal Epithelial Cells, donor2	11606-120I4	6.83	2.28	4.55	3.41
Corneal Epithelial Cells, donor3	11687-122I4	8.44	4.35	7.92	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.38	6.93	5.61	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.44	5.99	8.83	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	6.90	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	19.33	10.91	9.61	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	39.97	5.47	16.06	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	30.03	3.92	15.67	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	51.30	4.84	13.07	3.39
Endothelial Cells - Aortic, donor0	11207-116A1	16.51	6.17	8.00	1.00
Endothelial Cells - Aortic, donor1	11263-116G3	11.15	6.45	6.45	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	10.46	5.09	7.07	1.41
Endothelial Cells - Aortic, donor3	11412-118E8	17.30	6.29	7.86	1.97
Endothelial Cells - Artery, donor1	11264-116G4	9.31	5.24	4.65	0.00
Endothelial Cells - Artery, donor2	11341-117F9	13.65	7.53	7.06	0.24
Endothelial Cells - Artery, donor3	11413-118E9	12.27	6.31	4.91	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	12.86	5.54	4.88	0.89
Endothelial Cells - Lymphatic, donor2	11317-117D3	17.04	12.17	4.87	0.91
Endothelial Cells - Lymphatic, donor3	11393-118C7	13.25	10.15	8.18	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	10.99	5.94	5.94	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	11.45	5.21	4.69	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	11.48	7.51	5.25	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	14.40	8.40	6.80	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	6.29	4.19	2.62	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	30.32	10.31	7.45	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	21.07	8.69	7.17	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	18.20	7.94	6.47	1.10
Endothelial Cells - Vein, donor1	11267-116G7	13.65	3.41	6.83	0.00
Endothelial Cells - Vein, donor2	11344-117G3	11.87	4.89	6.29	2.10
Endothelial Cells - Vein, donor3	11416-118F3	9.58	6.75	6.12	0.31
Eosinophils, donor1	12244-129H3	30.49	15.25	15.25	0.00
Eosinophils, donor2	12245-129H4	56.11	8.25	6.60	0.00
Eosinophils, donor3	12246-129H5	35.67	7.13	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	6.35	2.69	3.91	0.73
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	0.00	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	13.55	8.21	2.87	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.12	4.38	5.04	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.54	6.28	7.80	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.07	7.52	7.16	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	11.05	5.87	3.68	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.81	8.12	6.86	1.05
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	7.64	2.37	2.11	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	13.95	10.96	11.29	2.33
Fibroblast - Cardiac, donor1	11268-116G8	9.53	6.80	5.44	0.45
Fibroblast - Cardiac, donor2	11345-117G4	10.61	2.27	3.03	0.00
Fibroblast - Cardiac, donor3	11417-118F4	6.47	5.52	4.42	0.47
Fibroblast - Cardiac, donor4	11452-119A3	22.73	10.91	7.58	1.21
Fibroblast - Cardiac, donor5	11456-119A7	11.42	6.85	6.73	1.02
Fibroblast - Cardiac, donor6	11460-119B2	15.61	10.01	5.00	1.06
Fibroblast - Choroid Plexus, donor1	11492-119E7	23.98	7.91	8.04	1.34
Fibroblast - Choroid Plexus, donor2	11572-120E6	21.57	3.02	3.02	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	8.79	7.32	1.46	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	16.14	14.53	10.15	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	24.08	9.67	7.29	1.19
Fibroblast - Dermal, donor1	11269-116G9	11.27	4.46	5.40	1.17
Fibroblast - Dermal, donor2	11346-117G5	16.98	10.85	8.49	0.94
Fibroblast - Dermal, donor3	11418-118F5	11.24	5.20	5.68	1.21
Fibroblast - Dermal, donor4	11450-119A1	9.61	7.57	6.90	0.45
Fibroblast - Dermal, donor5	11454-119A5	11.69	5.41	7.33	0.52
Fibroblast - Dermal, donor6	11458-119A9	12.51	7.31	7.31	1.62
Fibroblast - Gingival, donor1	11237-116D4	18.95	7.50	7.91	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.01	8.38	9.17	1.57
Fibroblast - Gingival, donor2	11318-117D4	13.18	8.17	7.64	1.19
Fibroblast - Gingival, donor3	11394-118C8	22.53	11.89	8.41	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	16.62	10.39	6.23	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	10.22	8.99	5.64	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	23.54	10.13	10.76	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	23.39	6.63	7.44	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.12	7.06	6.00	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	18.13	7.75	6.87	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	21.41	6.00	9.14	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	21.06	8.01	7.24	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	16.43	7.78	7.78	1.32
Fibroblast - Lung, donor1	11270-116H1	8.16	5.44	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	25.37	4.48	7.46	2.98
Fibroblast - Lung, donor3	11419-118F6	9.50	7.18	6.75	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	34.99	15.83	8.33	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	12.59	6.99	2.80	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	9.24	3.08	5.04	0.00
Fibroblast - Mammary, donor1	11540-120B1	34.10	14.21	10.15	1.22
Fibroblast - Mammary, donor2	11620-122A9	3.99	0.00	7.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	14.16	7.37	6.60	1.94
Fibroblast - Periodontal Ligament, donor2	11319-117D5	13.95	10.01	9.40	1.21
Fibroblast - Periodontal Ligament, donor3	11395-118C9	22.95	13.46	13.77	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	15.26	5.72	5.34	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	17.82	7.83	6.21	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	14.15	8.12	8.70	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	13.15	6.52	6.85	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	34.75	15.65	11.79	2.03
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	7.35	4.01	5.35	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.79	7.12	9.09	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	10.91	4.17	2.18	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	15.10	7.46	6.39	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	12.81	9.46	4.14	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.53	1.50	2.11	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	21.59	9.07	6.59	1.40
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	12.91	5.31	1.01	0.51
Fibroblast - skin normal, donor1	11553-120C5	13.95	8.37	6.07	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.03	3.81	1.60	0.20
Fibroblast - skin normal, donor2	11561-120D4	16.38	8.94	7.43	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	13.90	6.04	3.63	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.98	7.21	6.30	0.91
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	19.32	10.26	4.10	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.57	4.60	2.63	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	21.41	13.00	8.95	1.70
Fibroblast - skin walker warburg, donor1	11554-120C6	18.22	9.78	8.60	1.52
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	11.92	5.02	3.14	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	20.05	1.74	4.36	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	10.05	7.80	9.19	2.60
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	13.53	9.11	8.07	2.60
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	10.73	9.20	11.50	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	14.55	2.30	9.95	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	10.85	1.91	7.66	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	4.85	4.56	9.70	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	3.58	6.62	7.72	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	6.16	4.11	4.34	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	4.56	4.16	4.36	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	2.91	5.55	6.87	1.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	8.48	2.94	5.87	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	7.52	3.98	4.86	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	3.96	3.67	10.03	1.98
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	6.53	7.27	8.00	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	6.72	2.95	3.76	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	5.82	4.34	8.80	1.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	5.54	4.29	9.00	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	5.69	3.66	5.29	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	7.07	8.67	8.21	3.19
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	4.98	6.23	8.47	1.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	5.25	4.81	7.87	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	7.39	7.68	6.21	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	5.40	5.40	9.54	1.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	5.59	8.71	6.93	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	8.47	6.65	8.87	1.41
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	8.82	6.62	10.35	1.36
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	15.25	8.25	6.56	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	10.41	10.41	8.84	2.19
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	10.93	8.88	10.93	3.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	6.64	8.96	9.85	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.15	5.57	7.07	1.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	9.19	7.15	10.41	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	7.01	6.81	6.81	2.06
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	5.07	7.15	10.61	1.50
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	5.84	8.51	8.67	1.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	7.27	7.05	9.70	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	6.89	9.22	9.35	1.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	8.59	9.08	7.46	1.30
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	10.26	8.34	8.98	1.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	6.06	6.06	8.15	1.23
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	7.75	8.70	8.70	1.90
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	6.99	4.87	6.99	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	5.96	7.63	10.14	1.88
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	6.37	9.22	9.22	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	7.29	8.42	5.33	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	7.41	7.13	9.07	1.39
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.70	5.35	4.81	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.33	9.79	8.57	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	8.42	9.33	10.62	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	14.64	7.32	9.49	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	10.69	9.03	7.19	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.53	8.11	8.77	2.41
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	10.91	17.85	7.93	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	11.61	8.97	6.07	1.58
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	9.48	6.66	7.06	1.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	28.47	27.96	21.86	4.83
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	10.35	2.99	9.16	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.39	4.47	7.70	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	6.14	4.09	9.41	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.14	3.44	5.63	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	9.89	1.98	7.35	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	8.76	0.92	6.00	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	4.95	4.95	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	11.60	5.80	10.44	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	4.81	3.21	6.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	10.43	3.48	1.74	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	5.53	4.56	7.81	1.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	4.94	3.29	7.82	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	9.79	3.92	9.51	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	9.48	3.92	7.52	2.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	9.23	3.36	5.87	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	9.54	4.45	8.91	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.83	6.11	7.47	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	4.18	8.35	10.44	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	7.45	6.87	9.74	2.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	7.10	5.03	9.18	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	15.25	5.08	11.86	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	17.40	7.87	5.80	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	14.27	6.44	7.82	1.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	7.69	4.23	8.84	2.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	14.67	7.17	10.11	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.03	6.69	4.68	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.94	6.55	6.93	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	20.20	7.87	4.11	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	4.97	2.48	9.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.44	4.72	8.97	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	8.45	7.85	9.05	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	10.68	5.09	9.66	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.76	5.98	4.79	2.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	13.32	6.91	9.87	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	5.90	4.72	4.72	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	7.00	4.67	5.83	1.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.97	7.90	7.02	1.76
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	5.09	7.63	8.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	7.76	6.57	7.16	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	9.22	2.91	6.31	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	3.42	4.57	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.56	6.65	2.91	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	14.62	11.24	7.87	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	16.81	4.12	5.39	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	16.71	3.76	3.34	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.66	8.12	6.73	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	14.85	8.78	7.93	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	16.84	4.78	9.56	0.68
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	17.27	6.23	9.07	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.05	8.81	9.46	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	11.41	6.89	4.95	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.31	8.59	9.09	1.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	12.01	5.32	8.06	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.17	7.37	6.41	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	17.91	12.31	7.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	9.09	5.19	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	21.15	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.52	8.47	10.58	1.76
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.08	9.44	7.99	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.86	6.64	5.77	0.52
Hepatocyte, donor1	11523-119I2	38.74	6.05	3.63	0.00
Hepatocyte, donor2	11603-120I1	37.71	16.16	7.54	0.00
Hepatocyte, donor3	11684-122I1	28.22	12.88	8.59	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	16.32	16.32	20.89	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	21.15	8.74	9.61	1.22
Iris Pigment Epithelial Cells, donor1	11530-119I9	11.11	7.41	4.53	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	15.92	47.76	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	40.05	60.08	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	11.08	18.00	44.30	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	10.01	35.04	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	35.60	35.60	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	12.81	7.69	41.01	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57	45.71	9.14
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	11.37	17.87	79.59	3.25
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	33.35	56.69	8.34
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	3.63	54.46	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	21.18	67.50	7.94
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	11.09	17.74	47.67	2.22
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	5.24	89.05	15.71
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.75	14.49	63.62	8.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	9.28	41.76	7.73
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	29.27	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	20.67	14.86	72.36	9.04
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	19.32	70.84	8.05
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	35.84	35.84	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	22.82	17.11	82.30	6.52
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	14.69	13.85	42.40	9.24
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	43.12	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	12.06	13.66	87.60	9.64
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	17.54	12.93	64.63	10.16
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	30.16	15.08	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	14.63	21.24	80.25	8.50
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	10.88	16.33	61.67	3.63
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	44.23	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	10.76	12.91	78.56	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	17.79	16.52	43.20	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	16.43	65.72	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	18.49	14.67	55.48	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	3.65	40.10	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	63.22	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	14.28	14.28	51.41	5.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	13.27	43.14	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	41.70	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	12.04	12.04	61.42	6.48
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	5.27	12.29	45.66	10.54
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	6.29	40.86	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	9.04	13.21	73.71	6.26
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	6.64	22.13	79.67	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	9.73	51.87	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	10.46	16.57	74.11	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	4.50	27.00	51.75	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	13.94	10.45	66.21	6.97
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	16.00	60.81	5.33
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	15.24	60.96	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	14.25	2.85	25.65	8.55
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	8.28	16.57	76.40	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	15.13	18.15	72.61	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	6.21	49.67	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	9.52	22.20	71.90	3.17
Keratinocyte - epidermal, donor1	11272-116H3	7.10	2.77	4.49	0.98
Keratinocyte - epidermal, donor2	11349-117G8	6.44	2.93	4.10	0.00
Keratinocyte - epidermal, donor3	11421-118F8	8.14	7.76	10.22	1.23
Keratinocyte - oral, donor1	11251-116E9	8.63	9.19	11.58	1.25
Keratocytes, donor1	11527-119I6	22.35	21.32	16.85	1.03
Keratocytes, donor2	11607-120I5	7.03	8.20	7.03	0.00
Keratocytes, donor3	11688-122I5	9.48	13.63	4.94	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	15.39	17.58	4.40
Lens Epithelial Cells, donor1	11529-119I8	9.71	6.47	7.55	0.00
Lens Epithelial Cells, donor2	11609-120I7	8.77	12.57	10.03	1.73
Lens Epithelial Cells, donor3	11690-122I7	14.63	6.56	3.83	1.21
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	11.98	8.77	4.62	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	12.56	6.70	5.58	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	15.74	7.08	5.51	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.59	5.91	9.14	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.28	6.62	3.78	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.94	6.15	3.99	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	5.34	6.57	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	14.16	6.07	4.55	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	12.10	7.60	3.94	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	9.89	3.56	4.35	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	12.60	6.01	6.01	0.97
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	10.55	4.63	5.74	0.93
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	12.54	6.62	5.57	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	19.08	6.92	6.20	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	13.73	5.49	4.67	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	11.70	4.62	7.39	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.03	3.74	4.68	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	14.64	5.12	3.84	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	12.84	4.61	5.59	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	13.18	3.22	4.39	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	9.71	3.49	4.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	9.70	4.36	7.76	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	11.58	4.58	4.58	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.89	7.57	6.51	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	9.33	5.18	7.26	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	14.45	4.82	6.07	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	10.83	4.81	7.97	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	11.69	2.75	6.88	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	11.29	3.95	6.40	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	12.19	6.79	4.77	0.53
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	11.63	7.27	8.72	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	14.89	4.63	4.96	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.27	4.46	5.70	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.55	5.92	5.92	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.37	4.69	4.20	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	10.86	3.44	4.95	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	11.90	5.47	1.93	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	13.39	5.48	6.39	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	14.42	5.60	5.60	1.40
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	11.02	6.04	6.40	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	8.73	2.42	3.88	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	8.87	4.67	3.42	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.09	7.16	4.30	1.07
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	11.43	7.84	4.57	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	9.65	3.77	4.94	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	13.37	10.15	5.94	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.01	3.33	4.61	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	15.22	5.67	5.37	0.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	13.60	2.27	9.06	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	16.11	3.84	5.37	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	2.97	2.97	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	18.19	2.96	3.81	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	14.77	2.11	4.22	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	12.14	6.54	3.74	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.97	1.55	5.15	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	8.33	7.14	8.33	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	18.32	6.11	3.62	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	19.19	5.23	5.82	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	16.66	7.65	6.75	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	22.63	6.64	6.64	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.89	4.11	6.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	18.00	8.12	6.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	23.99	4.66	8.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	16.81	3.06	7.13	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	17.88	8.27	5.87	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	15.49	6.42	4.72	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	16.57	7.98	4.29	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	9.79	5.71	5.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	14.37	5.41	6.87	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	16.26	6.73	5.89	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	12.36	7.21	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	13.64	6.68	7.55	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	17.64	3.59	4.48	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	14.38	8.30	4.43	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	17.32	5.30	9.90	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.28	3.32	3.32	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	14.97	1.15	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	11.51	4.61	4.22	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	16.42	2.26	4.53	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	16.41	9.03	4.10	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	11.75	3.16	4.97	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	0.72	5.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	12.70	13.44	3.73	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	14.49	4.09	4.46	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	15.94	4.74	2.15	2.15
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	6.85	1.71	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.66	5.66	2.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	11.46	4.22	3.02	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	12.80	2.84	5.69	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.72	6.19	3.44	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	9.66	3.76	3.76	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	4.71	5.39	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	17.78	7.41	4.82	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	3.49	4.65	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	9.52	10.58	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	16.01	4.40	4.40	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	19.63	2.18	4.36	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	19.93	8.43	8.43	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	7.89	5.92	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	22.58	0.94	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	17.10	9.55	5.03	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	15.32	5.86	5.86	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	3.44	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	20.04	12.91	5.79	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	16.42	7.82	3.13	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	17.81	2.64	6.60	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	22.83	8.82	6.75	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	16.19	5.69	6.13	1.75
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	16.77	3.35	2.24	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	16.78	4.86	4.42	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	20.44	5.01	3.86	1.16
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	23.80	5.57	3.04	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	15.86	6.73	5.29	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	19.08	8.75	5.17	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	17.62	4.86	2.43	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.83	4.15	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.58	6.84	4.18	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	13.94	3.10	1.55	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.91	1.81	6.65	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	12.99	4.75	4.44	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	15.99	3.73	4.80	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.67	5.75	5.75	1.15
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.86	5.66	4.63	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	17.68	2.83	4.24	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.62	4.54	6.24	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	12.06	6.24	4.16	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	9.40	3.92	2.35	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	16.28	5.01	2.09	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	16.73	5.58	5.11	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	10.04	4.68	0.67	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	9.62	4.81	5.88	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	10.51	4.85	3.64	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.93	5.51	3.67	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	1.78	5.33	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	11.97	7.41	2.28	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	3.07	3.83	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.32	6.57	5.47	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	13.81	6.24	4.01	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	11.70	6.50	3.90	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	17.90	3.98	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	12.47	8.31	4.16	4.16
Macrophage - monocyte derived, donor1	11232-116C8	31.00	7.98	8.89	0.68
Macrophage - monocyte derived, donor2	11313-117C8	17.43	12.48	8.07	0.73
Macrophage - monocyte derived, donor3	11389-118C3	26.48	13.76	8.78	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	10.09	2.12	4.78	1.06
Mallassez-derived cells, donor2	11929-125I3	9.35	8.40	9.03	2.22
Mallassez-derived cells, donor3	11930-125I4	10.42	6.67	7.92	0.97
Mammary Epithelial Cell, donor1	11273-116H4	19.93	6.18	7.77	1.20
Mammary Epithelial Cell, donor2	11350-117G9	14.48	7.82	8.11	0.58
Mammary Epithelial Cell, donor3	11422-118F9	5.74	3.74	6.24	1.25
Mast cell - stimulated, donor1	11487-119E2	71.18	23.73	12.88	0.68
Mast cell, donor1	11563-120D6	56.67	22.82	8.11	0.87
Mast cell, donor2	11565-120D8	33.88	13.37	12.78	1.78
Mast cell, donor3	11566-120D9	30.17	15.31	14.63	2.25
Mast cell, donor4	11567-120E1	25.71	13.83	11.52	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	37.37	9.76	7.87	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	39.11	2.33	4.09	1.17
Mast cell, expanded, donor5	11939-126A4	41.76	13.65	7.57	0.92
Mast cell, expanded, donor8	11941-126A6	70.80	13.89	11.55	1.34
Melanocyte - dark, donor1	11502-119F8	26.57	14.23	10.45	1.49
Melanocyte - dark, donor2	11582-120F7	14.54	6.58	3.81	0.69
Melanocyte - dark, donor3	11663-122F7	22.46	15.86	12.82	1.01
Melanocyte - light, donor1	11274-116H5	6.58	3.76	4.70	0.94
Melanocyte - light, donor2	11351-117H1	6.82	5.46	6.14	0.00
Melanocyte - light, donor3	11423-118G1	3.47	2.60	2.60	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	17.70	12.08	13.33	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	18.83	7.53	6.72	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	21.96	12.32	7.77	1.61
Meningeal Cells, donor1	11493-119E8	29.53	11.66	10.42	2.11
Meningeal Cells, donor2	11573-120E7	31.69	14.08	8.80	0.00
Meningeal Cells, donor3	11654-122E7	22.49	7.74	7.66	1.22
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	13.69	12.83	5.13	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	14.29	5.74	4.63	1.31
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	5.26	2.63	2.63	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	2.62	3.92	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	10.76	4.31	6.46	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.67	6.35	5.51	1.27
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	13.57	6.53	5.03	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	16.48	7.91	7.91	1.76
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	9.50	9.50	8.77	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	10.84	6.34	8.18	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	12.74	8.73	5.12	0.83
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	9.66	5.20	3.72	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	16.32	6.45	4.08	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	20.48	5.64	3.26	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.17	5.76	8.33	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	16.66	5.67	8.51	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	9.69	5.63	7.51	1.56
Mesenchymal stem cells - umbilical, donor0	11214-116A8	6.53	5.81	9.43	0.00
Mesothelial Cells, donor1	11247-116E5	19.36	8.49	11.40	1.33
Mesothelial Cells, donor2	12156-128G5	20.02	6.51	9.51	3.00
Mesothelial Cells, donor3	11402-118D7	11.63	7.08	7.37	1.37
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	56.71	16.20	12.15	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	39.40	16.50	13.05	1.48
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	36.22	15.02	12.07	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	10.37	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	32.23	14.57	10.54	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	32.15	11.20	11.82	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	6.95	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	32.03	15.77	10.26	1.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.94	18.15	7.45	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	38.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	29.87	15.44	9.35	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	31.68	11.48	9.90	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	18.58	8.85	7.96	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	31.15	9.50	9.88	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	7.90	7.90	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	21.86	9.34	9.13	0.64
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	5.52	10.13	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	22.35	8.05	7.45	2.09
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	8.38	5.03	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	17.56	6.27	5.52	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	28.04	6.65	8.56	1.43
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	19.90	11.06	4.98	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	15.43	5.99	6.22	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	23.35	9.25	7.78	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	11.01	7.13	5.10	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	19.95	7.72	6.44	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	22.45	8.45	6.89	1.11
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.73	4.60	5.69	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	20.79	9.13	5.07	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	21.54	3.31	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	9.78	4.62	6.52	1.63
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.53	6.18	7.94	1.47
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	2.18	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	10.09	3.84	3.84	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.81	6.40	6.40	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	9.60	5.48	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.01	6.01	7.51	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	53.89	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	4.08	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	10.07	3.94	3.94	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	11.04	6.62	6.62	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.20	11.53	4.48	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	13.64	4.71	4.71	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	6.96	6.96	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	11.05	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.62	7.18	6.50	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	11.38	9.19	7.88	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.43	3.20	7.10	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	15.15	7.29	5.89	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	7.07	8.31	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	5.83	4.08	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.16	4.22	9.35	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	21.70	10.43	9.60	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	21.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	13.85	9.24	9.24	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	15.37	5.69	11.95	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.57	7.46	8.98	0.55
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.55	8.03	9.07	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	22.31	12.01	6.43	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	6.35	7.62	6.99	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	15.21	3.47	4.80	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	17.66	11.37	12.57	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.29	5.65	7.63	0.99
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	12.10	7.01	7.33	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	19.24	11.28	9.29	0.88
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.00	7.20	5.31	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	12.78	6.53	5.68	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	18.68	10.82	7.13	1.23
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	9.12	8.47	7.17	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	12.94	6.76	5.88	0.59
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	27.68	10.67	12.40	1.15
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	30.50	11.54	6.59	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	24.42	12.21	8.04	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	24.95	12.48	3.56	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.37	9.20	5.26	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	10.52	5.26	5.26	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	30.05	6.92	4.94	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	46.57	11.18	11.18	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	25.16	8.64	10.89	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	30.90	10.12	9.32	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	20.81	7.24	5.77	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	5.16	2.95	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	25.28	8.43	6.60	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	17.11	6.22	4.67	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.36	4.81	2.67	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	15.46	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	15.15	9.09	7.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	16.02	9.28	5.90	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	4.09	6.81	2.72	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.89	0.64	3.18	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	4.05	2.43	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	1.51	4.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	11.42	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	9.50	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	25.10	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	16.80	6.68	5.82	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.20	10.97	5.75	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	5.34	3.34	2.00	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	8.35	5.01	4.59	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	8.56	3.99	4.56	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	28.73	3.19	6.38	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	2.72	0.68	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	1.84	5.51	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.12	4.19	2.09	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.58	5.11	5.11	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	8.65	3.78	2.43	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.56	5.26	6.94	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	11.91	4.96	5.96	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.01	2.71	3.79	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	7.93	4.99	4.76	1.13
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	7.68	3.43	3.76	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.03	6.20	4.92	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	13.79	5.83	5.30	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.81	2.40	5.40	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	8.86	3.61	1.97	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	6.50	4.23	4.23	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.70	8.64	10.41	1.59
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	6.33	4.22	3.52	1.41
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	9.19	3.68	3.68	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.64	5.14	2.57	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	11.38	4.14	2.76	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	22.76	7.59	10.11	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	12.92	4.90	6.68	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.47	1.69	1.69	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	8.31	3.32	3.09	0.47
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.44	5.15	3.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	0.00	9.03	36.11	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	5.00	7.00	3.67	1.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.08	6.31	7.21	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	4.76	0.79	3.17	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	2.79	2.79	3.71	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	9.08	4.54	6.43	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.56	5.21	3.26	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	10.02	5.67	3.49	1.31
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	12.21	6.33	10.40	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	2.65	2.65	1.76	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	3.32	3.32	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	4.96	6.94	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	7.66	4.21	4.21	1.15
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	8.17	3.02	3.33	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.95	3.54	3.54	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.03	3.39	2.71	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	3.66	7.93	4.27	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	4.72	4.09	5.35	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	3.93	3.33	3.63	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	3.96	6.33	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	11.34	1.13	2.27	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	19.75	9.07	8.57	1.12
Myoblast, donor2	11322-117D8	15.73	10.36	7.48	1.15
Myoblast, donor3	11398-118D3	29.43	14.29	11.77	2.19
NK T cell leukemia cell line:KHYG-1	10777-110G3	18.24	14.74	10.65	0.58
Natural Killer Cells, donor1	11230-116C6	28.29	6.46	7.38	1.54
Natural Killer Cells, donor2	11311-117C6	29.25	9.05	10.86	3.02
Natural Killer Cells, donor3	11387-118C1	23.56	9.02	9.94	1.29
Neural stem cells, donor1	11275-116H6	24.68	8.35	13.79	0.73
Neural stem cells, donor2	11352-117H2	19.26	26.96	17.33	3.85
Neurons, donor1	11494-119E9	13.65	9.10	7.97	2.28
Neurons, donor2	11574-120E8	9.03	10.79	8.81	3.08
Neurons, donor3	11655-122E8	8.22	9.04	9.04	1.64
Neutrophils, donor1	11233-116C9	28.77	12.99	10.21	0.93
Neutrophils, donor2	11314-117C9	17.39	11.60	2.90	2.90
Neutrophils, donor3	11390-118C4	28.10	24.43	10.38	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	25.53	9.97	7.84	1.07
Nucleus Pulposus Cell, donor2	11409-118E5	17.58	8.79	5.21	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	9.02	8.42	4.81	1.20
Olfactory epithelial cells, donor1	11933-125I7	14.73	5.23	5.23	1.10
Olfactory epithelial cells, donor2	11934-125I8	14.19	5.36	4.78	1.88
Olfactory epithelial cells, donor3	11935-125I9	11.80	5.33	5.33	1.14
Olfactory epithelial cells, donor4	11936-126A1	10.81	7.21	3.90	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	8.43	16.85	10.23	1.20
Osteoblast - differentiated, donor1	11276-116H7	10.00	5.74	3.62	1.28
Osteoblast - differentiated, donor2	11353-117H3	12.57	4.57	4.57	0.00
Osteoblast - differentiated, donor3	11425-118G3	16.14	3.72	6.21	0.00
Osteoblast, donor1	11277-116H8	18.18	3.71	5.86	0.59
Osteoblast, donor2	11354-117H4	10.53	6.32	6.32	4.21
Osteoblast, donor3	11426-118G4	13.33	11.55	9.42	2.13
Pancreatic stromal cells, donor1	11249-116E7	23.25	8.76	6.23	0.67
Pericytes, donor1	11491-119E6	13.35	7.45	5.90	1.45
Pericytes, donor2	11571-120E5	11.77	7.47	7.70	1.58
Pericytes, donor3	11652-122E5	14.04	7.73	9.36	1.42
Perineurial Cells, donor1	11499-119F5	10.40	7.46	6.44	1.47
Perineurial Cells, donor2	11579-120F4	21.53	10.95	8.47	1.38
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	42.39	15.62	9.88	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.67	8.33	7.35	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	21.35	11.78	5.44	1.29
Placental Epithelial Cells, donor1	11278-116H9	4.54	4.30	3.59	0.72
Placental Epithelial Cells, donor2	11355-117H5	7.76	4.44	2.22	3.33
Placental Epithelial Cells, donor3	11427-118G5	5.30	4.12	5.10	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.39	6.01	4.11	0.95
Preadipocyte - breast, donor1	11467-119B9	12.76	4.13	5.25	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.14	4.57	1.04	0.52
Preadipocyte - breast, donor2	11328-117E5	14.86	8.11	4.50	1.35
Preadipocyte - omental, donor1	11468-119C1	10.76	4.80	3.84	0.75
Preadipocyte - omental, donor2	11329-117E6	10.48	11.78	6.11	0.87
Preadipocyte - omental, donor3	11403-118D8	9.88	8.17	6.88	1.58
Preadipocyte - perirenal, donor1	11469-119C2	5.91	5.91	6.89	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	15.36	4.30	4.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	23.55	9.74	7.61	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	16.86	4.94	6.64	0.51
Preadipocyte - visceral, donor1	11280-116I2	22.82	6.43	6.52	1.12
Preadipocyte - visceral, donor2	11357-117H7	22.09	6.90	4.14	0.00
Preadipocyte - visceral, donor3	11429-118G7	18.60	9.51	7.94	1.36
Prostate Epithelial Cells (polarized), donor1	11253-116F2	18.86	8.60	10.86	1.21
Prostate Epithelial Cells, donor2	11331-117E8	8.26	5.42	4.20	1.08
Prostate Epithelial Cells, donor3	11404-118D9	4.53	7.47	9.61	2.33
Prostate Stromal Cells, donor1	11254-116F3	15.26	9.80	6.72	0.57
Prostate Stromal Cells, donor2	11332-117E9	19.18	8.43	8.07	0.90
Prostate Stromal Cells, donor3	11405-118E1	19.92	8.55	6.67	1.15
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.76	9.85	7.66	2.19
Renal Cortical Epithelial Cells, donor2	11596-120H3	7.00	6.45	6.58	0.90
Renal Epithelial Cells, donor1	11517-119H5	4.57	7.61	3.04	0.51
Renal Epithelial Cells, donor2	11597-120H4	7.11	9.25	4.27	1.42
Renal Epithelial Cells, donor3	11678-122H4	8.68	6.99	6.03	1.59
Renal Glomerular Endothelial Cells, donor1	11514-119H2	10.21	3.40	6.81	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	13.34	8.76	8.89	1.21
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.10	5.99	5.11	1.78
Renal Glomerular Endothelial Cells, donor4	11783-124B1	5.99	5.99	5.99	0.67
Renal Mesangial Cells, donor1	11518-119H6	10.56	8.36	6.82	0.88
Renal Mesangial Cells, donor2	11598-120H5	7.52	4.39	8.15	0.63
Renal Mesangial Cells, donor3	11679-122H5	4.99	4.99	6.94	1.39
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	14.49	8.05	12.62	2.15
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.06	5.90	4.64	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	11.57	5.01	10.41	0.96
Retinal Pigment Epithelial Cells, donor0	11215-116A9	6.22	4.67	5.70	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	10.80	5.97	5.40	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	3.09	4.12	4.12	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	15.05	3.26	3.76	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	37.82	15.37	9.09	2.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	14.29	1.79	4.47	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	22.57	3.30	2.20	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	22.62	5.80	11.02	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	13.65	7.80	6.76	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	10.53	6.45	7.55	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	14.28	5.91	8.25	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	12.16	10.79	8.19	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	11.65	6.41	9.09	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.72	8.09	10.86	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	10.82	6.98	8.21	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	11.19	6.96	7.87	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	13.08	6.81	5.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	11.91	8.61	6.46	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	11.80	6.98	8.80	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	12.83	7.30	9.07	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	10.90	5.93	5.35	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	11.46	6.52	8.29	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	17.29	6.20	7.89	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.14	6.50	6.90	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	11.10	6.81	9.73	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	9.74	6.30	11.08	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	10.57	6.94	6.62	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	11.21	3.92	7.01	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	14.01	5.81	6.84	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.66	6.20	7.66	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.04	5.52	7.73	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	9.40	8.73	10.75	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	12.27	4.72	4.48	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	10.32	8.33	7.34	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	14.50	6.78	9.59	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.40	6.43	5.81	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	11.95	5.31	8.85	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	12.32	5.64	8.15	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.63	7.67	7.40	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	11.41	7.49	10.05	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	12.53	8.68	6.94	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	10.32	5.85	4.64	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	9.19	7.13	8.23	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	12.97	6.90	7.22	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	10.91	4.94	4.77	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	9.91	9.91	9.03	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	9.33	6.93	9.06	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	10.78	9.96	8.30	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	9.76	9.05	8.33	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	13.91	11.08	8.26	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	13.47	7.25	5.84	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	19.21	6.99	8.73	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	16.62	7.86	9.07	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	12.36	8.81	7.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	24.89	10.19	6.84	1.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	19.47	11.56	6.08	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	10.25	6.33	4.82	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	15.61	9.27	9.27	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	10.48	8.99	9.59	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	18.18	6.14	6.61	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	13.45	8.75	7.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	9.01	7.81	6.01	0.00
Schwann Cells, donor1	11498-119F4	11.28	8.65	6.02	1.13
Schwann Cells, donor2	11578-120F3	3.40	3.40	3.40	0.00
Schwann Cells, donor3	11659-122F3	10.30	5.48	8.54	0.88
Sebocyte, donor1	11220-116B5	19.72	16.98	14.24	1.10
Sebocyte, donor2	11301-117B5	13.79	3.68	6.89	1.38
Sebocyte, donor3	11378-118B1	12.16	8.86	6.60	0.41
Sertoli Cells, donor1	11255-116F4	24.85	11.60	4.97	0.00
Sertoli Cells, donor2	11333-117F1	14.12	8.47	5.65	0.00
Skeletal Muscle Cells, donor1	11281-116I3	16.10	6.51	4.13	0.79
Skeletal Muscle Cells, donor2	11358-117H8	9.40	4.34	2.89	0.00
Skeletal Muscle Cells, donor3	11430-118G8	5.02	4.18	2.51	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.34	3.46	5.50	0.47
Skeletal Muscle Cells, donor5	11455-119A6	15.46	5.80	6.54	1.04
Skeletal Muscle Cells, donor6	11459-119B1	11.70	11.39	9.23	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	22.56	8.95	5.92	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	20.55	8.99	8.99	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	15.08	10.52	8.04	1.39
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	18.79	5.73	7.33	1.35
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	7.24	7.96	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	10.73	4.54	3.44	0.83
Skin - palm, donor1	10286-104F7	24.17	2.69	13.43	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	5.77	2.16	5.91	1.15
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	10.63	1.64	3.27	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	5.45	2.99	6.23	0.52
Small Airway Epithelial Cells, donor1	11256-116F5	6.81	5.14	7.37	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	7.03	6.05	8.16	1.27
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	8.25	5.07	3.81	1.27
Small Airway Epithelial Cells, donor3	11406-118E2	6.30	11.62	12.59	1.50
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	14.19	10.49	4.32	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.67	2.22	2.22	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	8.23	4.11	2.94	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	7.96	3.98	2.43	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	16.54	5.91	6.30	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	6.95	3.86	5.41	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	27.02	5.00	4.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	6.12	4.26	3.33	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	16.85	6.21	5.98	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	10.50	9.09	6.40	1.54
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	14.98	9.12	7.16	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	15.95	10.04	6.50	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	11.39	9.25	6.83	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	11.39	9.11	7.16	1.30
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	15.22	5.18	6.09	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	7.32	3.28	2.78	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.29	4.29	3.34	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	12.68	5.01	6.05	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	11.84	3.87	5.60	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	10.92	9.13	6.30	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	16.09	6.96	6.03	1.39
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	14.01	5.39	2.16	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	5.98	4.18	5.38	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	16.05	10.24	9.56	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	24.74	9.66	6.83	1.41
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	11.67	5.13	6.24	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	22.07	8.42	6.37	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	4.23	1.21	1.81
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	15.90	11.13	7.42	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	20.37	10.12	7.19	1.33
Smooth Muscle Cells - Prostate, donor2	11335-117F3	15.53	7.51	5.63	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.25	5.58	4.82	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	16.13	6.78	5.73	0.90
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	10.50	9.75	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	9.05	2.58	3.88	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	12.09	2.33	1.40	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	6.56	6.06	4.04	1.51
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	7.21	5.95	4.70	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	16.22	8.85	4.72	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	21.41	13.25	11.00	1.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	20.56	9.34	7.01	1.87
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	9.64	4.46	5.61	1.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	11.98	7.65	7.90	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	10.34	5.83	3.57	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	13.42	11.04	9.36	1.54
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	12.32	11.90	6.54	1.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	5.24	3.81	6.67	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	9.30	8.56	4.65	0.98
Smooth Muscle Cells - Uterine, donor1	11258-116F7	14.14	8.40	5.30	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.66	8.19	3.80	0.88
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.41	2.92	2.53	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	9.26	2.38	3.97	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.23	3.72	2.23	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	23.72	5.39	5.39	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	17.60	3.41	11.64	2.27
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.42	3.54	5.91	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	12.95	2.79	5.08	0.76
Smooth muscle cells - airway, control, donor2	11967-126D5	7.99	2.00	3.59	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	10.87	2.09	3.76	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	8.25	1.38	2.75	0.00
Synoviocyte, donor1	11291-117A4	12.79	2.36	5.72	1.18
Synoviocyte, donor2	11368-117I9	12.57	9.05	5.53	0.50
Synoviocyte, donor3	11440-118H9	11.62	8.04	4.47	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	15.01	7.15	8.58	2.50
Trabecular Meshwork Cells, donor2	11612-122A1	11.89	0.00	7.93	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	7.87	6.71	6.02	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	8.32	5.30	8.10	1.29
Tracheal Epithelial Cells, donor2	11369-118A1	3.48	2.71	3.09	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	5.15	4.01	3.44	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	39.98	15.50	8.37	1.60
Urethra, donor2	10319-105A4	21.58	7.19	5.40	0.00
Urothelial Cells, donor1	11520-119H8	4.25	7.44	7.44	1.33
Urothelial Cells, donor2	11600-120H7	2.80	5.21	8.81	1.20
Urothelial Cells, donor3	11681-122H7	4.58	3.44	4.13	0.92
Urothelial cells, donor0	11216-116B1	4.90	5.80	10.92	1.56
Whole blood (ribopure), donor090309, donation1	12179-129A1	32.03	16.02	16.02	2.67
Whole blood (ribopure), donor090309, donation2	12180-129A2	30.02	17.16	11.44	2.86
Whole blood (ribopure), donor090309, donation3	12181-129A3	18.48	13.69	4.79	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	16.18	6.89	6.89	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	25.57	6.97	8.72	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	24.99	7.29	12.49	2.08
Whole blood (ribopure), donor090612, donation2	12183-129A5	26.62	17.44	8.26	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	16.43	10.95	4.56	0.00
Wilms' tumor cell line:G-401	10809-111A8	16.53	9.75	6.78	1.11
Wilms' tumor cell line:HFWT	10597-108E3	8.80	2.64	5.28	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	10.61	5.03	10.33	1.40
achilles tendon, donor2	10292-104G4	6.20	4.13	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	21.67	11.47	7.14	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	16.48	13.47	13.70	2.09
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	25.76	14.48	14.36	2.14
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	34.56	13.61	15.24	2.45
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	25.58	8.71	7.87	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	47.58	8.67	8.67	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	22.32	4.36	8.98	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	14.54	3.97	7.05	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	45.33	5.72	15.11	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	29.90	14.76	13.20	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	8.65	5.15	10.49	2.02
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	31.20	3.90	7.80	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	33.00	8.13	11.15	1.86
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	15.79	6.21	14.50	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.95	5.26	9.35	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	17.20	5.11	8.83	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	16.45	8.64	13.57	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	9.21	4.60	9.82	2.15
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	19.63	8.53	11.52	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	19.71	11.53	19.11	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	21.66	13.96	17.57	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	24.72	5.12	7.13	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	28.02	7.67	7.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	24.16	9.29	35.31	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	41.06	9.42	10.92	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	38.38	8.29	14.83	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	22.49	9.37	13.12	1.87
adenocarcinoma cell line:IM95m	10796-110I4	14.37	7.06	7.77	2.83
adipose tissue, adult, pool1	10010-101C1	19.08	11.32	8.07	0.62
adipose, donor1	10184-103D4	9.38	5.28	9.38	1.17
adipose, donor2	10185-103D5	5.68	5.68	6.08	3.65
adipose, donor3	10186-103D6	5.45	5.45	6.26	0.54
adipose, donor4	10187-103D7	6.07	1.73	6.07	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	5.37	5.37	7.89	2.37
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	20.54	12.94	9.74	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	12.15	4.29	4.29	0.71
amniotic membrane cells, donor1	12235-129G3	9.04	8.58	7.65	3.01
amniotic membrane cells, donor2	12236-129G4	10.14	11.50	11.83	1.01
amniotic membrane cells, donor3	12237-129G5	7.37	7.66	8.84	2.65
amygdala - adult, donor10196	10167-103B5	27.27	13.04	5.93	0.00
amygdala, adult, donor10252	10151-102I7	17.03	15.00	6.08	0.61
amygdala, newborn, donor10223	10360-105E9	12.59	2.90	6.46	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	21.39	17.06	9.80	1.40
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	17.21	8.38	5.74	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	17.37	5.34	5.68	1.00
aorta, adult, pool1	10052-101G7	13.73	8.24	4.51	0.59
appendix, adult	10189-103D9	25.23	6.21	10.09	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	16.85	4.82	6.19	1.03
artery, adult	10190-103E1	12.23	12.23	6.79	2.72
astrocytoma cell line:TM-31	10425-106D2	12.17	10.00	11.59	1.59
b cell line:RPMI1788	10427-106D4	11.30	5.20	5.80	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	19.98	15.26	10.54	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	21.53	6.95	5.56	0.79
bile duct carcinoma cell line:TFK-1	10496-107C1	21.59	7.36	4.52	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.61	5.59	10.07	1.12
bladder, adult, pool1	10011-101C2	14.45	10.32	5.11	1.52
blood, adult, pool1	10053-101G8	13.29	4.43	6.64	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	12.85	7.71	7.71	2.57
bone marrow, adult	10192-103E3	25.64	8.10	7.42	0.67
brain, adult, donor1	10084-102B3	6.15	11.28	4.10	1.03
brain, adult, pool1	10012-101C3	14.25	10.24	6.35	1.67
brain, fetal, pool1	10085-102B4	2.67	10.69	2.67	5.34
breast carcinoma cell line:MCF7	10482-107A5	32.05	10.24	6.94	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	44.94	19.10	16.35	2.00
breast, adult, donor1	10080-102A8	10.10	8.84	4.42	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.15	3.94	4.19	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	9.59	4.33	6.18	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	27.40	10.36	2.99	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	31.47	13.31	13.31	0.97
carcinoid cell line:NCI-H1770	10703-109H1	5.64	6.11	9.40	0.94
carcinoid cell line:NCI-H727	10735-110B6	22.75	12.14	20.13	2.19
carcinoid cell line:SK-PN-DW	10719-109I8	5.70	3.80	9.19	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	36.47	12.78	11.18	1.06
caudate nucleus - adult, donor10196	10177-103C6	9.21	16.12	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	10.71	16.57	7.03	0.67
caudate nucleus, adult, donor10258	10379-105H1	6.88	8.41	6.88	0.76
caudate nucleus, newborn, donor10223	10354-105E3	8.06	1.10	4.39	1.46
cerebellum - adult, donor10196	10173-103C2	17.48	5.83	14.57	0.00
cerebellum, adult, donor10252	10166-103B4	13.02	23.06	12.38	4.27
cerebellum, adult, pool1	10083-102B2	8.62	11.73	6.21	0.69
cerebellum, newborn, donor10223	10357-105E6	9.13	4.98	9.96	1.66
cerebral meninges, adult	10188-103D8	17.65	11.09	7.82	2.77
cerebrospinal fluid, donor2	10294-104G6	3.65	2.19	6.58	0.73
cervical cancer cell line:D98-AH2	10552-107I3	16.82	5.90	3.02	0.14
cervical cancer cell line:ME-180	10553-107I4	10.94	8.62	6.46	0.66
cervix, adult, pool1	10013-101C4	20.58	8.19	6.82	1.99
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	25.08	4.74	2.51	0.42
chondrosarcoma cell line:SW 1353	10700-109G7	5.23	2.61	9.14	0.00
choriocarcinoma cell line:BeWo	10423-106C9	26.60	13.79	11.68	1.12
choriocarcinoma cell line:SCH	10785-110H2	30.80	20.82	15.16	1.11
choriocarcinoma cell line:T3M-3	10618-108G6	23.01	13.28	11.38	1.19
chorionic membrane cells, donor1	12238-129G6	9.40	16.53	11.97	1.42
chorionic membrane cells, donor2	12239-129G7	13.22	15.71	12.53	2.68
chorionic membrane cells, donor3	12240-129G8	11.54	10.44	7.69	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	21.21	13.13	11.11	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	18.44	3.65	7.49	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	30.83	17.11	15.84	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	12.58	22.34	77.81	12.33
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	17.90	26.12	96.99	17.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	18.32	23.42	89.79	16.90
chronic myelogenous leukemia cell line:K562	10454-106G4	28.27	33.57	89.51	9.42
chronic myelogenous leukemia cell line:KU812	10409-106B4	16.94	9.38	17.20	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	11.66	10.97	10.51	1.60
clear cell carcinoma cell line:TEN	10636-108I6	5.73	3.30	3.12	0.17
colon carcinoma cell line:CACO-2	10513-107D9	24.16	9.15	9.52	1.10
colon carcinoma cell line:COLO-320	10420-106C6	14.06	9.88	17.48	1.90
colon, adult, donor1	10082-102B1	14.28	8.33	4.76	1.19
colon, adult, pool1	10014-101C5	26.67	13.16	5.88	1.18
colon, fetal, donor1	10070-101I7	14.21	12.98	6.80	1.85
common myeloid progenitor CMP, donor1	12130-128D6	18.33	0.00	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	21.67	5.10	4.67	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	26.26	3.47	4.98	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	24.96	5.22	5.50	0.71
corpus callosum, adult, pool1	10042-101F6	17.69	19.02	9.18	1.66
cruciate ligament, donor2	10295-104G7	12.97	2.43	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	12.04	8.03	4.82	0.00
diencephalon, adult	10193-103E4	7.68	11.28	4.32	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	9.64	3.90	13.55	2.53
ductal cell carcinoma cell line:KLM-1	10438-106E6	27.95	12.82	16.41	2.31
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	15.41	8.67	9.39	0.72
ductus deferens, adult	10196-103E7	17.44	9.97	11.46	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	7.20	4.32	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	20.60	7.36	4.41	1.47
dura mater, adult, donor1	10041-101F5	31.47	11.64	13.13	1.07
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.32	13.10	9.77	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.50	9.89	11.75	2.44
embryonic pancreas cell line:1B2C6	10604-108F1	14.18	5.55	4.32	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	12.41	7.87	4.24	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	15.13	7.10	3.70	0.93
embryonic pancreas cell line:2C6	10603-108E9	19.70	19.70	3.94	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	32.51	4.69	4.02	1.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	19.57	10.33	8.88	1.81
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	9.65	6.59	11.26	1.45
epidermoid carcinoma cell line:A431	10426-106D3	22.12	11.67	9.12	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	18.70	14.96	13.64	1.43
epididymis, adult	10197-103E8	14.86	6.49	5.02	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	14.37	7.10	4.79	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	3.93	1.97	1.97	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	12.45	6.29	4.59	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	16.24	8.86	3.84	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	14.00	8.40	4.03	0.22
esophagus, adult, pool1	10015-101C6	18.79	9.03	7.01	0.74
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	74.14	11.40	7.01	1.38
eye - muscle inferior rectus, donor1	10272-104E2	9.66	0.00	9.66	0.00
eye - muscle lateral, donor2	10298-104H1	14.73	0.00	6.31	2.10
eye - muscle medial, donor2	10299-104H2	11.91	1.49	0.00	1.49
eye - muscle superior, donor2	10297-104G9	5.73	2.29	5.73	0.00
eye - vitreous humor, donor1	10268-104D7	11.66	5.83	0.00	0.00
eye, fetal, donor1	10054-101G9	9.92	9.15	6.61	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	13.21	3.59	3.08	0.64
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	28.97	13.53	5.46	1.19
frontal lobe, adult, pool1	10040-101F4	23.17	11.73	7.60	1.78
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	15.61	2.40	0.60	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	7.22	9.51	9.69	2.56
gall bladder, adult	10198-103E9	23.42	10.14	9.17	0.97
gamma delta positive T cells, donor1	11937-126A2	21.47	5.91	3.76	0.54
gamma delta positive T cells, donor2	11938-126A3	54.53	10.08	9.71	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.25	4.86	5.91	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	11.60	1.16	1.74	0.19
gastric cancer cell line:AZ521	10549-107H9	22.79	11.31	12.46	1.64
gastric cancer cell line:GSS	10560-108A2	5.49	2.75	10.98	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	21.47	7.08	8.22	1.14
giant cell carcinoma cell line:LU65	10487-107B1	2.64	1.38	1.03	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	28.41	9.38	8.26	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	19.95	8.48	5.74	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	14.78	3.80	5.59	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	19.66	9.13	5.20	0.98
glioblastoma cell line:T98G	10485-107A8	35.10	11.04	7.17	0.99
glioma cell line:GI-1	10413-106B8	15.82	9.66	8.49	2.05
globus pallidus - adult, donor10196	10175-103C4	10.20	10.20	2.19	1.46
globus pallidus, adult, donor10252	10161-103A8	17.09	21.48	10.01	1.71
globus pallidus, adult, donor10258	10367-105F7	10.95	5.48	5.48	0.00
globus pallidus, newborn, donor10223	10364-105F4	9.59	3.73	3.20	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	9.79	14.68	12.24	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	5.23	20.91	0.00
granulosa cell tumor cell line:KGN	10624-108H3	5.44	2.88	1.60	0.64
hIPS +CCl2, biol_rep1	14383-156B9	3.67	2.30	6.43	0.00
hIPS +CCl2, biol_rep2	14384-156C1	6.40	0.91	5.03	0.46
hIPS +CCl2, biol_rep3	14385-156C2	5.15	1.93	9.02	0.64
hIPS, biol_rep1	14380-156B6	4.31	1.44	1.44	0.00
hIPS, biol_rep2	14381-156B7	4.80	0.69	2.74	0.00
hIPS, biol_rep3	14382-156B8	16.55	3.31	7.72	2.21
hairy cell leukemia cell line:Mo	10712-109I1	10.34	4.88	7.76	0.57
heart - mitral valve, adult	10205-103F7	16.74	10.46	6.58	1.49
heart - pulmonic valve, adult	10206-103F8	17.78	7.84	6.54	1.57
heart - tricuspid valve, adult	10207-103F9	21.65	9.16	5.83	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	8.98	10.41	5.10	1.02
heart, adult, diseased, donor1	10051-101G6	8.94	11.92	5.11	1.70
heart, adult, pool1	10016-101C7	16.79	18.40	10.35	3.22
heart, fetal, pool1	10046-101G1	14.27	16.22	9.86	2.26
hepatic mesenchymal tumor cell line:LI90	10778-110G4	6.48	8.02	6.79	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	13.08	3.57	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	23.20	14.25	8.18	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	23.18	15.29	6.68	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	30.42	14.65	7.38	0.51
hepatoma cell line:Li-7	10484-107A7	18.46	11.12	7.01	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	19.70	9.55	8.64	1.01
hippocampus - adult, donor10196	10169-103B7	8.52	4.73	7.57	0.95
hippocampus, adult, donor10252	10153-102I9	14.70	20.41	5.92	1.63
hippocampus, adult, donor10258	10374-105G5	13.94	2.49	6.97	0.00
hippocampus, newborn, donor10223	10363-105F3	7.40	1.41	3.52	1.41
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	4.27	0.61	2.44	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	6.48	3.14	5.50	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	5.84	1.78	5.33	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	1.69	1.69	8.46	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	3.10	3.87	8.52	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.31	1.14	7.21	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	8.47	2.34	5.26	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	10.99	6.89	8.40	1.72
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	7.09	3.75	11.26	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	12.79	5.92	3.55	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	8.84	6.43	6.91	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	14.14	4.71	12.12	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	7.67	2.19	4.23	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.86	3.44	5.90	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	10.47	0.00	7.85	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	5.35	3.25	10.69	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	3.49	4.80	7.85	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	5.50	2.50	7.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	4.33	3.77	6.22	2.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.91	7.28	8.18	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	4.70	2.82	7.52	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	10.78	6.86	6.21	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	9.87	6.39	8.42	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	10.16	1.20	5.08	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	7.02	3.14	4.99	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	5.71	3.42	8.27	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	7.35	2.45	3.67	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	7.04	5.28	9.86	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	7.60	6.65	5.07	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	7.87	5.14	8.17	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	7.76	3.10	5.17	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.96	5.31	4.65	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.75	3.33	4.10	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	9.20	5.88	7.67	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	11.36	5.30	6.82	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	12.10	3.02	6.05	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	4.59	3.86	5.55	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	8.91	2.67	6.24	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	7.32	1.95	2.44	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	4.89	4.89	7.03	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	9.76	19.52	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	6.29	3.31	8.27	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	8.76	6.57	12.04	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.88	2.53	8.69	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	9.61	3.56	4.63	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	4.77	3.58	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	12.05	5.55	7.99	1.22
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	8.89	1.89	4.85	0.54
immature langerhans cells, donor1	11904-125F5	27.60	2.66	5.33	0.97
immature langerhans cells, donor2	11905-125F6	22.97	2.38	9.51	0.79
insula, adult, pool1	10039-101F3	30.00	15.99	8.42	1.80
keratoacanthoma cell line:HKA-1	10791-110H8	12.03	7.15	4.88	0.33
kidney, adult, pool1	10017-101C8	19.52	10.91	8.01	1.50
kidney, fetal, pool1	10045-101F9	13.30	10.47	6.86	1.41
large cell lung carcinoma cell line:IA-LM	10509-107D5	9.52	6.39	5.82	0.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	7.60	3.87	3.59	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.58	20.37	15.05	0.73
left atrium, adult, donor1	10079-102A7	12.53	8.72	5.99	0.54
left ventricle, adult, donor1	10078-102A6	10.62	9.10	6.57	0.51
leiomyoblastoma cell line:G-402	10721-110A1	21.07	5.75	6.84	1.37
leiomyoma cell line:10964C	10569-108B2	14.73	7.18	7.54	1.44
leiomyoma cell line:15242A	10570-108B3	16.85	3.26	6.52	0.54
leiomyoma cell line:15425	10571-108B4	14.57	8.50	7.28	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	6.35	12.70	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	16.73	7.32	8.36	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	20.42	9.68	6.85	1.18
liposarcoma cell line:KMLS-1	10782-110G8	9.37	7.65	4.37	0.62
liposarcoma cell line:SW 872	10726-110A6	11.45	8.89	10.36	1.46
liver, adult, pool1	10018-101C9	38.89	15.07	6.32	0.32
liver, fetal, pool1	10086-102B5	13.17	8.47	4.70	1.88
locus coeruleus - adult, donor10196	10182-103D2	7.73	5.83	3.94	0.73
locus coeruleus, adult, donor10252	10165-103B3	8.49	13.47	6.46	0.74
locus coeruleus, adult, donor10258	10375-105G6	7.90	3.67	5.08	1.97
locus coeruleus, newborn, donor10223	10362-105F2	10.52	3.36	5.47	0.00
lung adenocarcinoma cell line:A549	10499-107C4	15.09	6.37	5.12	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	14.48	6.89	4.14	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	27.02	11.73	14.10	1.32
lung, adult, pool1	10019-101D1	13.23	9.21	4.73	0.95
lung, fetal, donor1	10068-101I5	21.69	7.71	6.56	1.71
lung, right lower lobe, adult, donor1	10075-102A3	16.04	8.71	4.12	0.00
lymph node, adult, donor1	10077-102A5	20.35	6.15	7.57	0.47
lymphangiectasia cell line:DS-1	10727-110A7	28.71	13.15	5.92	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	23.70	14.04	9.81	1.36
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	59.46	12.74	5.10	0.85
mature adipocyte, donor1	12231-129F8	15.98	11.99	7.99	0.89
mature adipocyte, donor2	12232-129F9	15.98	13.49	5.19	1.25
mature adipocyte, donor3	12233-129G1	10.19	8.53	5.45	0.95
mature adipocyte, donor4	12234-129G2	20.53	9.74	6.58	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	17.39	10.72	16.20	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	15.79	9.02	3.38	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	16.74	14.71	7.17	2.21
medial frontal gyrus, adult, donor10258	10368-105F8	10.17	5.08	2.54	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	9.81	2.13	5.54	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	18.90	9.11	5.23	0.84
medial temporal gyrus, adult, donor10252	10156-103A3	16.77	17.19	5.09	1.70
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	9.63	1.93	3.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	28.71	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	9.33	5.38	7.54	1.08
medulla oblongata - adult, donor10196	10174-103C3	9.09	7.79	4.54	0.00
medulla oblongata, adult, donor10252	10155-103A2	11.46	23.53	7.43	0.62
medulla oblongata, adult, pool1	10038-101F2	14.53	16.90	8.00	0.98
medulla oblongata, newborn, donor10223	10361-105F1	9.37	3.12	4.86	1.39
medulloblastoma cell line:D283 Med	10838-111E1	19.48	5.31	9.30	0.66
medulloblastoma cell line:ONS-76	10759-110E3	9.05	5.75	8.93	0.61
melanoma cell line:COLO 679	10514-107E1	28.89	17.39	16.82	2.30
melanoma cell line:G-361	10465-106H6	14.39	5.70	7.60	1.36
meningioma cell line:HKBMM	10691-109F7	9.23	5.97	5.07	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.96	11.46	19.39	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	16.33	12.96	14.00	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	24.09	10.59	7.36	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.91	10.00	4.91	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	12.84	3.73	4.97	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	10.54	7.02	6.74	1.26
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	11.55	6.16	5.97	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	9.02	6.94	5.55	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	9.61	8.24	7.04	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	10.12	6.33	4.49	0.58
mesenchymal precursor cell - cardiac, donor3	11754-123G8	11.41	5.31	4.11	0.40
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.34	8.78	5.94	0.95
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	9.96	7.68	6.69	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.26	3.29	3.29	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	9.69	7.61	5.53	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	11.17	8.38	6.28	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.35	6.33	6.74	2.25
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	8.27	5.39	5.03	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5.79	5.90	5.59	0.93
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.07	4.56	7.30	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	14.68	8.39	13.01	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	11.81	4.63	5.83	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	6.65	7.09	7.09	1.31
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.52	7.73	7.00	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.30	4.86	4.86	0.57
mesenchymal stem cell line:Hu5/E18	10568-108B1	20.63	10.10	6.32	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.50	4.11	6.85	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	13.81	6.39	4.86	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	14.13	5.76	5.76	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	14.79	6.16	4.93	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.30	4.71	3.53	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	11.17	3.38	7.11	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.90	5.11	3.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	13.90	2.78	5.10	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	13.84	6.35	7.50	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.72	7.59	5.80	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	17.55	5.29	4.81	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	17.60	8.80	5.87	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	15.78	3.69	4.70	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.69	7.37	5.73	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	14.60	1.72	3.87	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	19.14	8.20	8.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	14.62	3.25	5.85	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	0.00	10.18	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	15.99	4.26	1.60	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	11.45	3.27	4.09	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.99	4.66	2.33	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	16.89	4.97	3.97	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	4.77	0.00	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	13.64	3.56	5.34	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	19.50	2.44	3.66	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.10	3.80	3.80	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	22.07	2.76	4.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	4.30	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	7.98	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	13.78	6.89	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.08	3.26	3.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.86	1.59	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	14.74	4.72	2.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	13.09	5.92	1.25	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	10.69	0.00	5.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	11.83	4.73	4.73	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	5.14	7.70	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	11.01	2.75	4.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.82	3.96	6.43	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	12.34	3.36	2.24	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.36	1.91	3.82	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	15.72	8.06	9.67	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	10.90	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	16.47	8.87	12.67	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	11.53	10.92	5.46	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	6.59	5.77	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	10.32	3.57	1.79	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.73	4.54	6.81	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	9.17	3.06	8.15	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	28.63	6.96	1.55	1.55
mesothelioma cell line:ACC-MESO-1	10493-107B7	7.32	5.43	4.72	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	23.86	12.28	5.33	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	18.70	3.19	2.57	0.31
mesothelioma cell line:Mero-25	10850-111F4	9.76	11.35	6.35	0.45
mesothelioma cell line:Mero-41	10851-111F5	13.20	5.62	7.58	0.73
mesothelioma cell line:Mero-48a	10852-111F6	10.85	3.99	4.65	1.33
mesothelioma cell line:Mero-82	10853-111F7	15.51	6.83	5.26	1.05
mesothelioma cell line:Mero-83	10854-111F8	12.60	2.55	3.06	0.17
mesothelioma cell line:Mero-84	10855-111F9	9.61	4.04	4.55	0.00
mesothelioma cell line:Mero-95	10856-111G1	7.66	1.45	1.24	1.04
mesothelioma cell line:NCI-H2052	10847-111F1	21.20	7.79	5.80	0.66
mesothelioma cell line:NCI-H226	10846-111E9	12.31	2.90	1.99	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	28.70	11.96	12.98	1.37
mesothelioma cell line:NCI-H28	10845-111E8	10.94	3.31	4.07	0.76
mesothelioma cell line:No36	10857-111G2	14.35	3.59	4.57	0.33
mesothelioma cell line:ONE58	10858-111G3	13.55	5.69	6.77	0.54
migratory langerhans cells, donor1	11901-125F2	15.16	4.61	5.18	1.54
migratory langerhans cells, donor2	11902-125F3	17.22	5.13	6.11	1.47
migratory langerhans cells, donor3	11903-125F4	21.90	8.44	9.69	1.79
mixed mullerian tumor cell line:HTMMT	10689-109F5	9.47	14.69	6.53	0.98
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	4.66	9.11	3.60	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	28.56	13.59	9.68	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	19.03	6.09	6.28	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	27.16	16.45	11.83	0.92
myeloma cell line:PCM6	10474-106I6	14.23	8.90	4.55	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	19.28	4.06	9.13	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	15.50	6.08	4.90	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	4.01	11.25	12.48	1.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	4.41	9.63	7.50	1.18
nasal epithelial cells, donor2	12227-129F4	5.52	6.07	11.59	0.00
neuroblastoma cell line:CHP-134	10508-107D4	20.94	10.58	16.79	3.68
neuroblastoma cell line:NB-1	10539-107G8	29.75	14.41	9.92	1.87
neuroblastoma cell line:NBsusSR	10607-108F4	5.06	11.18	14.34	3.16
neuroblastoma cell line:NH-12	10555-107I6	14.54	9.32	9.13	0.93
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	8.30	2.85	8.07	1.42
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	6.02	9.98	11.56	1.74
neuroectodermal tumor cell line:TASK1	10774-110F9	11.67	7.25	5.84	1.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	3.18	3.81	19.07	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	14.37	6.12	4.79	1.06
neutrophil PMN, donor1	12133-128D9	14.87	0.00	74.37	14.87
neutrophil PMN, donor2	12137-128E4	0.00	13.28	13.28	0.00
neutrophil PMN, donor3	12141-128E8	28.41	9.47	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	14.21	14.71	17.42	1.69
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	6.40	4.00	3.20	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	9.30	9.30	4.81	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	26.01	11.04	10.51	1.05
nucleus accumbens, adult, pool1	10037-101F1	19.59	15.28	6.00	1.50
occipital cortex - adult, donor10196	10172-103C1	10.30	12.36	4.12	0.00
occipital cortex, adult, donor10252	10163-103B1	11.54	21.74	8.86	0.54
occipital cortex, newborn, donor10223	10355-105E4	13.83	3.28	4.00	1.09
occipital lobe, adult, donor1	10076-102A4	15.74	14.69	5.51	0.52
occipital lobe, fetal, donor1	10073-102A1	7.72	9.44	10.30	1.72
occipital pole, adult, pool1	10036-101E9	15.06	10.25	6.23	1.02
olfactory region, adult	10195-103E6	10.70	12.61	3.25	1.91
optic nerve, donor1	10277-104E7	16.01	18.01	8.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	26.88	9.11	9.00	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	6.73	9.75	10.72	0.96
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	17.78	9.48	10.33	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	8.78	2.89	2.77	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	12.64	6.47	7.64	0.88
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	34.57	26.16	9.34	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	12.09	7.00	7.00	0.85
ovary, adult, pool1	10020-101D2	14.68	9.61	7.08	2.10
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	7.88	11.37	11.37	2.20
pancreas, adult, donor1	10049-101G4	16.93	10.35	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	6.99	3.07	4.19	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	12.10	8.52	6.30	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	18.21	9.77	5.96	0.99
paracentral gyrus, adult, pool1	10035-101E8	18.95	13.09	6.96	0.73
parietal cortex, adult, donor10258	10373-105G4	9.54	5.87	5.87	0.73
parietal lobe - adult, donor10196	10171-103B9	9.40	3.76	4.70	0.00
parietal lobe, adult, donor10252	10157-103A4	19.10	12.54	7.70	0.57
parietal lobe, adult, pool1	10034-101E7	18.59	14.72	6.34	1.15
parietal lobe, fetal, donor1	10072-101I9	3.88	8.73	3.88	0.97
parietal lobe, newborn, donor10223	10356-105E5	12.34	4.11	5.61	0.75
parotid gland, adult	10199-103F1	13.57	13.57	19.73	2.47
penis, adult	10200-103F2	13.43	10.21	9.13	3.22
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	15.80	5.58	7.25	1.30
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	30.16	36.72	25.93	2.04
pineal gland - adult, donor10196	10179-103C8	8.39	12.26	7.74	1.29
pineal gland, adult, donor10252	10160-103A7	18.95	23.69	12.44	5.33
pineal gland, adult, donor10258	10377-105G8	17.56	5.64	7.52	0.00
pituitary gland - adult, donor10196	10180-103C9	5.06	7.08	14.17	2.02
pituitary gland, adult, donor10252	10162-103A9	13.03	21.89	7.30	0.52
pituitary gland, adult, donor10258	10378-105G9	6.81	8.51	1.70	0.00
placenta, adult, pool1	10021-101D3	25.26	13.55	11.40	3.12
plasma cell leukemia cell line:ARH-77	10840-111E3	15.10	4.63	7.15	0.93
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	16.34	11.83	5.45	0.78
pons, adult, pool1	10033-101E6	13.43	13.17	6.28	0.69
postcentral gyrus, adult, pool1	10032-101E5	15.34	10.72	6.63	1.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	10.46	20.91	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	11.74	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	20.54	16.46	14.42	2.18
prostate cancer cell line:PC-3	10439-106E7	17.42	14.34	9.26	0.91
prostate, adult, pool1	10022-101D4	14.87	7.89	6.26	1.81
putamen, adult, donor10196	10176-103C5	11.09	14.87	4.49	0.71
putamen, adult, donor10252	10152-102I8	13.73	1.96	11.76	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	2.19	6.56	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	12.81	7.73	7.01	1.21
putamen, newborn, donor10223	10365-105F5	5.25	0.75	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	119.28	45.09	39.28	3.49
rectum, fetal, donor1	10067-101I4	9.74	9.74	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	21.84	7.84	7.42	1.06
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	2.07	2.90	2.90	0.41
retina, adult, pool1	10030-101E3	27.73	14.41	9.94	1.29
retinoblastoma cell line:Y79	10475-106I7	21.04	10.39	9.61	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	15.98	5.78	6.89	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	46.40	12.37	9.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	19.70	10.61	8.34	3.03
salivary acinar cells, donor1	11771-123I7	16.35	6.47	5.99	0.97
salivary acinar cells, donor2	11772-123I8	19.55	4.68	6.61	0.41
salivary acinar cells, donor3	11773-123I9	19.86	9.27	9.27	1.99
salivary gland, adult, pool1	10093-102C3	13.73	5.72	13.73	2.29
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.06	6.24	3.79	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	8.23	8.93	6.00	0.24
seminal vesicle, adult	10201-103F3	22.75	6.88	10.05	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.06	4.62	1.94	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	8.56	5.54	10.57	2.77
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	19.07	8.03	14.05	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	33.98	13.30	10.61	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	19.23	8.73	7.41	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	15.61	4.77	4.77	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	13.48	11.35	7.80	2.13
skeletal muscle, adult, pool1	10023-101D5	16.67	20.39	9.12	2.40
skeletal muscle, fetal, donor1	10066-101I3	9.05	6.03	4.02	1.01
skin, adult, donor1	10074-102A2	6.79	0.00	6.79	0.00
skin, fetal, donor1	10065-101I2	13.26	7.57	4.42	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	9.01	6.67	14.68	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	6.62	4.41	3.78	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	7.32	8.67	16.00	2.70
small cell lung carcinoma cell line:LK-2	10541-107H1	11.70	6.43	8.57	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	6.92	2.25	5.31	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	24.62	8.50	8.28	0.22
small intestine, adult, pool1	10024-101D6	26.40	10.51	8.60	0.84
small intestine, fetal, donor1	10064-101I1	19.66	8.35	5.16	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	16.93	7.18	3.59	1.03
smooth muscle, adult, pool1	10048-101G3	11.37	13.70	4.91	1.29
somatostatinoma cell line:QGP-1	10781-110G7	7.77	4.02	5.36	1.61
spinal cord - adult, donor10196	10181-103D1	8.49	8.49	3.90	0.69
spinal cord, adult, donor10252	10159-103A6	12.62	20.11	9.86	2.37
spinal cord, adult, donor10258	10369-105F9	9.69	2.77	8.30	0.69
spinal cord, fetal, donor1	10056-101H2	16.47	9.76	7.93	0.00
spinal cord, newborn, donor10223	10359-105E8	10.56	2.76	7.35	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	11.95	10.16	7.92	1.19
spleen, adult, pool1	10025-101D7	28.86	12.78	7.82	0.99
spleen, fetal, pool1	10044-101F8	26.38	9.61	8.34	1.75
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	16.46	5.18	7.45	1.35
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.65	12.72	9.68	0.76
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	13.98	5.59	5.24	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	5.08	6.65	4.69	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	4.61	5.52	5.97	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	7.62	2.97	6.78	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	21.15	11.00	5.92	0.00
stomach, fetal, donor1	10062-101H8	24.56	12.82	12.82	0.00
submaxillary gland, adult	10202-103F4	14.81	11.39	9.11	2.28
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	11.01	19.94	9.76	1.25
substantia nigra, adult, donor10258	10371-105G2	12.41	5.69	4.14	1.03
substantia nigra, newborn, donor10223	10358-105E7	9.19	3.53	6.36	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.18	11.92	18.34	3.44
temporal lobe, adult, pool1	10031-101E4	22.38	12.29	8.05	1.02
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.27	14.96	7.83	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	5.71	6.59	10.11	2.64
tenocyte, donor1	11763-123H8	11.87	7.33	6.28	0.70
tenocyte, donor2	11765-123I1	8.01	7.25	4.20	1.14
tenocyte, donor3	11768-123I4	11.86	7.41	4.08	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.24	8.84	9.35	0.85
teratocarcinoma cell line:NCR-G1	10798-110I6	11.56	6.63	4.16	0.31
teratocarcinoma cell line:PA-1	10807-111A6	8.21	7.13	8.83	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.22	7.24	10.66	1.40
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.70	3.40	4.92	1.13
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	9.92	7.74	10.25	1.53
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	8.47	3.26	12.05	0.65
testis, adult, pool1	10026-101D8	16.43	19.22	35.22	2.47
testis, adult, pool2	10096-102C6	16.69	21.20	76.68	1.80
thalamus - adult, donor10196	10168-103B6	8.83	7.73	5.52	0.00
thalamus, adult, donor10252	10154-103A1	13.60	21.25	7.19	1.88
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.58	5.60	2.80	0.16
thalamus, newborn, donor10223	10366-105F6	6.33	4.03	2.88	0.00
throat, adult	10209-103G2	14.73	7.24	8.74	1.75
throat, fetal, donor1	10061-101H7	9.75	9.14	6.09	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	26.23	5.56	10.14	1.99
thymus, adult, pool1	10027-101D9	16.30	13.22	11.53	2.29
thymus, fetal, pool1	10043-101F7	21.40	12.57	11.01	1.87
thyroid carcinoma cell line:KHM-5M	10776-110G2	31.91	10.90	13.83	1.73
thyroid carcinoma cell line:TCO-1	10783-110G9	8.10	10.20	7.68	0.28
thyroid, adult, pool1	10028-101E1	14.93	13.44	8.30	1.40
thyroid, fetal, donor1	10060-101H6	10.02	8.70	7.12	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	21.56	6.16	9.24	3.08
tongue, adult	10203-103F5	15.12	5.12	9.54	1.16
tongue, fetal, donor1	10059-101H5	13.01	12.22	7.88	1.97
tonsil, adult, pool1	10047-101G2	18.13	12.62	12.72	1.80
trachea, adult, pool1	10029-101E2	19.06	11.37	9.00	1.64
trachea, fetal, donor1	10058-101H4	10.00	10.00	7.31	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	17.01	8.15	10.27	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	12.66	7.70	9.83	2.33
transitional-cell carcinoma cell line:JMSU1	10492-107B6	19.43	7.21	2.35	0.16
tridermal teratoma cell line:HGRT	10694-109G1	13.32	3.81	11.42	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	22.86	10.75	5.42	1.10
umbilical cord, fetal, donor1	10057-101H3	8.35	6.26	4.17	0.00
uterus, adult, pool1	10100-102D1	24.91	8.19	6.83	1.88
uterus, fetal, donor1	10055-101H1	11.77	11.26	6.14	1.02
vagina, adult	10204-103F6	16.80	9.05	3.88	1.94
vein, adult	10191-103E2	21.92	10.30	7.67	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.75	5.07	4.01	0.80